Evaluation and medical management of the patient with calcium stone disease.
About 80 per cent of renal stones seen in the western hemisphere are composed of calcium and oxalate. The authors discuss some of the metabolic disorders involved in calcium stone disease, describe a comprehensive metabolic work-up for the patient who forms stones recurrently, and suggest some guidelines for treatment.
D000328:Adult; D002129:Calcium Oxalate; D002482:Cellulose / Q000031:analogs & derivatives / Q000627:therapeutic use; D006801:Humans; D006875:Hydrotherapy; D007669:Kidney Calculi / Q000175:diagnosis / Q000178:diet therapy / Q000188:drug therapy* / Q000209:etiology; D008274:Magnesium / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010710:Phosphates / Q000627:therapeutic use; D011336:Probability; D012008:Recurrence; D012306:Risk; D013843:Thiazines / Q000627:therapeutic use
D010710:Phosphates; D013843:Thiazines; D002129:Calcium Oxalate; D002482:Cellulose; C008881:phosphocellulose; D008274:Magnesium